1. Home
  2. ADM vs ONC Comparison

ADM vs ONC Comparison

Compare ADM & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer-Daniels-Midland Company

ADM

Archer-Daniels-Midland Company

HOLD

Current Price

$82.47

Market Cap

38.6B

ML Signal

HOLD

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$361.90

Market Cap

40.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ADM
ONC
Founded
1902
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.6B
40.6B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
ADM
ONC
Price
$82.47
$361.90
Analyst Decision
Hold
Strong Buy
Analyst Count
11
28
Target Price
$80.40
★ $432.80
AVG Volume (30 Days)
★ 3.1M
361.5K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
★ 2.58%
N/A
EPS Growth
N/A
★ 140.43
EPS
★ 2.49
0.31
Revenue
★ $80,269,000,000.00
$238,387,000.00
Revenue This Year
$7.64
$26.70
Revenue Next Year
$4.82
$14.57
P/E Ratio
★ $31.94
$1,157.32
Revenue Growth
N/A
★ 22179.16
52 Week Low
$55.58
$253.95
52 Week High
$88.75
$385.22

Technical Indicators

Market Signals
Indicator
ADM
ONC
Relative Strength Index (RSI) 50.08 53.46
Support Level $76.16 $327.01
Resistance Level $84.10 $370.11
Average True Range (ATR) 2.18 7.56
MACD -0.54 -0.13
Stochastic Oscillator 42.67 61.40

Price Performance

Historical Comparison
ADM
ONC

About ADM Archer-Daniels-Midland Company

Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

Share on Social Networks: